Effect of Antacid on Bioavailability of Febuxostat After Administration of a Febuxostat 80 mg Extended-Release Capsule
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the effect of antacid administration, and its timing,
on the bioavailability of a single dose of febuxostat extended-release (XR) 80 mg.